UPDATE: Edesa Biotech, Inc. (Nasdaq: EDSA) has just announced groundbreaking results from its Phase 3 study of paridiprubart (EB05) for treating Acute Respiratory Distress Syndrome (ARDS)....
UPDATE: Thousands of protesters have flooded the streets of Manila today, October 8, 2023, demanding justice and accountability in a massive corruption scandal implicating lawmakers, officials,...